Latest filing published 10 Jan 2018 for Valeant Pharmaceuticals International, Inc., €58k. Read the official filing
Christina Ackermann appears in our data through filings on Valeant Pharmaceuticals International, Inc. shares, published by SEDI. Over a trading history stretching from 8 August 2016 to 8 January 2018, the count stands at 5 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 10 January 2018 with a transaction (€58k) in Valeant Pharmaceuticals International, Inc. Between a trade and the moment it shows up on SEDI, the median delay is 5 days. That lag is the time during which only the insider knows about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations